- Patent Title: Autoantibodies to Septin-7 and diagnosis of neurological disease
-
Application No.: US17114984Application Date: 2020-12-08
-
Publication No.: US11835519B2Publication Date: 2023-12-05
- Inventor: Ramona Miske , Madeleine Scharf , Lars Komorowski , Yvonne Denno , Stefanie Hahn , Christiane Radzimski , Mandy Unger , Andrew McKeon , Sean Pittock , Thomas Kryzer , Vanda Lennon , Josephe Honorat
- Applicant: EUROIMMUN Medizinische Labordiagnostika AG , Mayo Foundation for Medical Education and Research
- Applicant Address: DE MN Luebeck
- Assignee: EUROIMMUN Medizinische Labordiagnostika AG,Mayo Foundation for Medical Education and Research
- Current Assignee: EUROIMMUN Medizinische Labordiagnostika AG,Mayo Foundation for Medical Education and Research
- Current Assignee Address: DE Luebeck; US MN Rochester
- Agency: Grüneberg and Myers PLLC
- Priority: EP 217147 2019.12.17
- Main IPC: G01N33/564
- IPC: G01N33/564 ; A61K38/17

Abstract:
A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
Public/Granted literature
- US20210181196A1 Diagnosis of a neurological disease Public/Granted day:2021-06-17
Information query
IPC分类: